SCHEMBL22402999

SCHEMBL22402999

CC(C)N1CCS(=O)(=O)c2cccnc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 11/20 0.40
JAK2 O60674 1/20 0.37
GRM5 P41594 1/20 0.33
CYP1A2 P05177 1/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
CYP2D6 P10635 1/20 0.32
CHRM1 P11229 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
DRD1 P21728 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTR7 P34969 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26542952 0.80 KCNN4 (0.39) KCNN4CHIA
SCHEMBL10094606 0.74 CA12 (0.34) CYP2D6CYP2C9KMT2A
SCHEMBL10094317 0.72 KCNN4 (0.33) KCNN4KMT2A
SCHEMBL12048949 0.69 MTNR1A (0.43) JAK2GRM5CHRM2HTR1AADRA2A
SCHEMBL15221563 0.69 KDM4E (0.37) JAK2GRM5CYP1A2CYP2C9
SCHEMBL10094622 0.69 HSD11B1 (0.37) KMT2A
SCHEMBL20571416 0.67 JAK2 (0.40) JAK2ADRA2AADRA2BADRA2CHTR2A
SCHEMBL10094120 0.67 JAK2 (0.49) JAK2ADRA2AADRA2BADRA2CHTR2A
SCHEMBL18237405 0.67 P2RX7 (0.33) KCNN4KMT2A
SCHEMBL17342856 0.66 JAK2 (0.45) JAK2CYP1A2ADRA2ACYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11786575-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2023-10-17 US disclosed
US-20220211802-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2022-07-07 US disclosed
US-11331369-B2 Endoparasitic depsipeptides ZOETIS SERVICES LLC (US) 2022-05-17 US disclosed
US-20200282016-A1 Endoparasitic Depsipeptides ZOETIS SERVICES LLC 2020-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11786575-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 KCNN4 2931/4885JAK2 3563/4885GRM5 4236/4885
US-20200282016-A1 Endoparasitic Depsipeptides VIP, PREP, NGLY1 KCNN4 2931/4885JAK2 3563/4885GRM5 4236/4885
US-20220211802-A1 Endoparasitic Depsipeptides VIP, PREP, NGLY1 KCNN4 2931/4885JAK2 3563/4885GRM5 4236/4885
US-11331369-B2 Endoparasitic depsipeptides VIP, PREP, NGLY1 KCNN4 2931/4885JAK2 3563/4885GRM5 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.